GSK said Friday that it has now sold 240 million shares in consumer healthcare business Haleon for 335 pence each, raising 804 million pounds ($1.01 billion), as first announced late Thursday. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results